BDBM526885 US11186577, Cmpd. No. 233

SMILES Clc1ccc-2c(CN(Cc3nnc(C4CC5(C4)CN(C5)c4ccncn4)n-23)C2CC2)c1

InChI Key InChIKey=CDVONQYVDAHPMQ-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 526885   

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526885(US11186577, Cmpd. No. 233)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent